BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27335021)

  • 1. [Hemato-oncological imaging : Importance of hybrid procedures].
    Mayerhoefer ME; Haug A
    Radiologe; 2016 Jul; 56(7):597-604. PubMed ID: 27335021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].
    Pinker K; Marino MA; Dr Meyer-Baese A; Helbich TH
    Radiologe; 2016 Jul; 56(7):612-21. PubMed ID: 27364727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].
    Stumpp P; Purz S; Sabri O; Kahn T
    Radiologe; 2016 Jul; 56(7):588-96. PubMed ID: 27306200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
    Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
    Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future Perspective of the Application of Positron Emission Tomography-Computed Tomography-MR Imaging in Musculoskeletal Disorders.
    Angelini A; Castellucci P; Ceci F
    PET Clin; 2019 Jan; 14(1):183-191. PubMed ID: 30420219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular breast imaging. An update].
    Pinker K; Helbich TH; Magometschnigg H; Fueger B; Baltzer P
    Radiologe; 2014 Mar; 54(3):241-53. PubMed ID: 24557495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
    Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hybrid imaging in lymphoma].
    Mayerhöfer ME; Haug A
    Radiologe; 2020 May; 60(5):376-385. PubMed ID: 32296856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI in colorectal and anal cancers: an update.
    Jayaprakasam VS; Ince S; Suman G; Nepal P; Hope TA; Paspulati RM; Fraum TJ
    Abdom Radiol (NY); 2023 Dec; 48(12):3558-3583. PubMed ID: 37062021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular imaging in neurological diseases].
    Reimold M; la Fougère C
    Radiologe; 2016 Jul; 56(7):580-7. PubMed ID: 27306201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.